Journal article · 2024 · Open access

Alzheimer Disease: Cognizance and Potential Aspect of Disease Pathophysiology & Recently Developed Therapeutic Drug Strategies

Rakesh Kumar Journal, Manita Saini, Tilottama Bhattacharya, Dr Deepika, Akancha Kumari

Journal of Drug Delivery and Therapeutics, 14(9), 232–239 · Published 15 September 2024 · DOI 10.22270/jddt.v14i9.6790

Free PDFView at the publisherCite this paper

In brief

“Alzheimer Disease: Cognizance and Potential Aspect of Disease Pathophysiology & Recently Developed Therapeutic Drug Strategies” is a 2024 journal article by Rakesh Kumar Journal and 4 co-authors, published in Journal of Drug Delivery and Therapeutics. OpenAlex counts 1 citations as of 15 November 2026, which puts it in the top 9% of works published in 2024 by citations. It is open access under a CC BY-NC licence: the full text is free to read at Journal of Drug Delivery and Therapeutics.

Citations
1
Most cited in
2026 (1)
Field-weighted impact
0.13
References
19
Authors
5

Abstract

Alzheimer’s disease (AD) is a multifactorial neuron-degenerative old age disease which has no cure. AD causes degeneration of the neuronal cells in the brain which is the main reason of dementia, characterized by a decline in the thinking and independence in daily routine activities. In most of the cases, AD is suspected to be caused by a combination of genetic, lifestyle and environmental factors, affecting the brain over time. The currently approved therapy, which includes cholinesterase inhibitors, NMDA-receptor antagonists and their combinations provides only temporary symptomatic relief. Nowadays, the clinical research is targeting on understanding of Alzheimer pathology1. These are targeting the abnormal tau protein metabolism, removal of beta-amyloid, inflammatory response, cholinergic neuron and free radical damage treatments which can either that stop or modify the course of Alzheimer. Global efforts are continued to identify new targets to develop novel therapeutic agents for the treatment of AD. Keywords: Alzheimer disease, Dementia, Drug therapy, Drug effect, Amyloid, Amyloid precursor protein, Tau proteins, Acetyl cholinesterase enzyme

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Journal, R. K., Saini, M., Bhattacharya, T., Deepika, D., & Kumari, A. (2024). Alzheimer Disease: Cognizance and Potential Aspect of Disease Pathophysiology & Recently Developed Therapeutic Drug Strategies. Journal of Drug Delivery and Therapeutics, 14(9), 232–239. https://doi.org/10.22270/jddt.v14i9.6790

MLA 9

Journal, Rakesh Kumar, et al. “Alzheimer Disease: Cognizance and Potential Aspect of Disease Pathophysiology & Recently Developed Therapeutic Drug Strategies.” Journal of Drug Delivery and Therapeutics, vol. 14, no. 9, 2024, pp. 232–239. https://doi.org/10.22270/jddt.v14i9.6790.

Chicago

Journal, Rakesh Kumar, Manita Saini, Tilottama Bhattacharya, Dr Deepika, and Akancha Kumari. 2024. “Alzheimer Disease: Cognizance and Potential Aspect of Disease Pathophysiology & Recently Developed Therapeutic Drug Strategies.” Journal of Drug Delivery and Therapeutics 14 (9): 232–239. https://doi.org/10.22270/jddt.v14i9.6790.

Harvard

Journal, R. K. et al. (2024) ‘Alzheimer Disease: Cognizance and Potential Aspect of Disease Pathophysiology & Recently Developed Therapeutic Drug Strategies’, Journal of Drug Delivery and Therapeutics, 14(9), pp. 232–239. doi:10.22270/jddt.v14i9.6790.

IEEE

R. K. Journal, M. Saini, T. Bhattacharya, D. Deepika, and A. Kumari, “Alzheimer Disease: Cognizance and Potential Aspect of Disease Pathophysiology & Recently Developed Therapeutic Drug Strategies,” Journal of Drug Delivery and Therapeutics, vol. 14, no. 9, pp. 232–239, 2024, doi: 10.22270/jddt.v14i9.6790.

BibTeX

@article{journal2024alzheimer,
  title     = {{Alzheimer Disease: Cognizance and Potential Aspect of Disease Pathophysiology \& Recently Developed Therapeutic Drug Strategies}},
  author    = {Journal, Rakesh Kumar and Saini, Manita and Bhattacharya, Tilottama and Deepika, Dr and Kumari, Akancha},
  journal   = {Journal of Drug Delivery and Therapeutics},
  year      = {2024},
  volume    = {14},
  number    = {9},
  pages     = {232--239},
  doi       = {10.22270/jddt.v14i9.6790},
  url       = {https://doi.org/10.22270/jddt.v14i9.6790}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments

  • Alzheimer's disease
  • dementia
  • disease pathophysiology
  • amyloid-beta
  • tau protein
  • acetylcholinesterase inhibitors
  • NMDA receptor antagonists
  • neuroinflammation

Work with this paper

Most-cited papers in Neuroscience

All highly cited Neuroscience papers

Questions about this paper

How do I cite this paper in APA style?

Journal, R. K., Saini, M., Bhattacharya, T., Deepika, D., & Kumari, A. (2024). Alzheimer Disease: Cognizance and Potential Aspect of Disease Pathophysiology & Recently Developed Therapeutic Drug Strategies. Journal of Drug Delivery and Therapeutics, 14(9), 232–239. https://doi.org/10.22270/jddt.v14i9.6790

How many times has this paper been cited?

1 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Journal of Drug Delivery and Therapeutics.

Who wrote this paper?

Rakesh Kumar Journal, Manita Saini, Tilottama Bhattacharya, Dr Deepika, Akancha Kumari.

What is the DOI of this paper?

10.22270/jddt.v14i9.6790. The permanent link is https://doi.org/10.22270/jddt.v14i9.6790.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.